EC-104 Intravitreal Implant

· Eclipse Life Sciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EC-104 Intravitreal Implant, covering 2025-01-22 to 2025-01-22. Get the full timeline:

Most recent: Clinical Trial Update: EC-104 Intravitreal Implant for the Treatment of Diabetic Macular Edema [Phase 1, Phase 2]